Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02683993 · ClinicalTrials.gov registry record · NA

Utilizing Holmium Laser for FURS Renal Stone Lithotripsy Comparing Stone Breaking vs. Stone Dusting Settings

A NA study, sponsored by Boston Scientific Corporation.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT02683993 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02683993, a NA study, has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Twenty (20) subjects presenting with a renal stone and candidates for FURS (flexible ureteroscopic renal surgery) will undergo a single FURS procedure for a kidney stone as part of the study, using the study device. These subjects will be randomized into stone breaking treatment or stone dusting.

Interventions

  • DEVICE Lumenis Pulse 120H holmium laser system and 200 DFL ball tip fiber

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-02
Est. Completion 2017-01-31
Phase NA

Sponsor

Boston Scientific Corporation

280 total trials

What the Registry Record Tells You About NCT02683993

The ClinicalTrials.gov registry entry for NCT02683993 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Lumenis Pulse 120H holmium laser system and 200 DFL ball tip fiber is the first listed.

NCT02683993 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02683993 about?

NCT02683993 is a clinical study titled "Utilizing Holmium Laser for FURS Renal Stone Lithotripsy Comparing Stone Breaking vs. Stone Dusting Settings". Twenty (20) subjects presenting with a renal stone and candidates for FURS (flexible ureteroscopic renal surgery) will undergo a single FURS procedure for a kidney stone as part of the study, using the study device. These subjects will be randomized into stone breaking treatment or stone dusting.

What is the current status of trial NCT02683993?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-02. Estimated completion is 2017-01-31.

What interventions are being tested in trial NCT02683993?

The interventions under investigation include: Lumenis Pulse 120H holmium laser system and 200 DFL ball tip fiber (DEVICE).

Who is sponsoring clinical trial NCT02683993?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.